Pene has sold real estate in Auckland since 2001, and two years ago merged her business Milne & Co Real Estate with NZ Sotheby’s International Realty, and joined Sotheby’s as a Sales Associate. Prior to this, Pene was a senior nurse manager and clinical risk manager working for the Tauranga District Health Board over 18 years.
Pene was diagnosed with Non-Hodgkin lymphoma in 1996 and has been in remission since 2004 after extensive treatments culminated in a bone marrow transplant. She has three adult children and a real appreciation of the challenges to be faced with diagnosis and treatment issues while supporting and raising young children.
Tony had been a company director since 1987 in the dairy industry; including positions with the NZ Dairy Group and the NZ Dairy board prior to the formation of Fonterra in 2001.
Tony and wife Sally have 5 children, now adults. Tony has been a regular blood donor for the past 30 years and is also now a monthly plasma donor.
Peter is a Professor of Pathology and Head of the Department of Molecular Medicine and Pathology at the University of Auckland School of Medicine, Consultant Haematologist at Auckland City Hospital, and Consultant Haematologist at Diagnostic Medlab.
His involvement with Leukaemia & Blood Cancer New Zealand stems from his clinical interest in the management of patients with haematological malignancies, including blood cell and bone marrow transplantation. In the laboratory, he has an interest in cell marker and molecular studies in the diagnosis and monitoring of patients with leukaemia, lymphoma and inherited blood disorders. Peter has had a long association with LBC, acting as Medical Director and trustee for many years.
Andrew is Chief Executive of Housing New Zealand, a Crown entity responsible for stewardship and management of the governments 61,000 state houses.
Andrew holds a BCA and a BA from the University of Wellington and is a Chartered Accountant. Prior to his current role, Andrew held senior finance roles at Fletcher Building, Auckland Council, Auckland City Council and Wellington City Council for six years. In 2013, he was recognised as the EY New Zealand CFO of the year.
Mark is Chief Executive of Profiler Tech, a high-tech startup company.
Mark holds a B. Com from the University of Canterbury. Prior to his current role, Mark has held senior Finance and management roles in both national and international companies including more recently, General Electric Inc.
Mark is involved with other Community Organizations and Chartable Trusts. He is currently Secretary of the local Saint Vincent De Paul Society and a Trustee of the North West Christchurch Community and Sporting Trust.
Personal interests include reading, travel, rugby, cycling and multisport. Married to Rose, with one son (26 years) and one daughter (24 years).
Ned is a director of the Manukau-based law firm, Kayes Fletcher Walker Limited, which holds the warrant to prosecute all serious crime in South Auckland on behalf of the Government. In 2015, he was awarded a PhD for his thesis on the meaning of the English text of the Treaty of Waitangi.
Ned was diagnosed with Acute Lymphoblastic Leukaemia and Burkett’s Lymphoma in 2012 and received chemotherapy treatment at Auckland Hospital. He and his family were involved in fundraising for the new haematology ward in 2014.
Shai was born and bred in London but has been in New Zealand since 2003. He has a Law Degree from the UK and has been in the financial services for over 10 years specialising in Risk Insurances and KiwiSaver. For years Shai has seen what he does has helped people financially at a time that people need help. The industry is a great industry to work in and he loves meeting and helping people and businesses.
Shai has been involved with many cancer claims over the years and has had a number of clients and friends diagnosed with Leukaemia. Being part of Leukaemia & Blood Cancer New Zealand has given him an opportunity to understand how amazing the organisation is and the great work they do.
Shai is also Chairperson for Business Whangaparaoa and Trustee of Future Whangaparaoa Trust.
Fale is a policy consultant at the Asian Development Bank and the Oceania representative on the board of NCD Child (a global subsidiary of Astra Zeneca). He’s currently the deputy chairman of the Auckland Conservation Board and a director at Emerge Aotearoa, MIT and UNITEC, Kidney Health New Zealand, and Diabetes Foundation Aotearoa.